Coronavirus COVID-19 Weekly Update 21st June 2021
Weekly update published on MedShr: 21st June 2021
Last updated: 21st June 2021
Every effort has been made to ensure that the information contained in this article is accurate and current at time of publication, but if you notice an error please contact covid@medshr.net and we will aim to address this. Please find MedShr’s full terms of service here.
Please post any anonymous educational COVID-19 cases, images or learning points from your clinical practice on MedShr - share key knowledge and experience with a global network of healthcare professionals to help improve patient care.
Please email COVID@medshr.net if you have any data, publications or information you would like to share.
Global Impact of COVID-19 to Date
Data from WHO Coronavirus Disease (COVID-19) Dashboard, reported on 20th June 2021
COVID-19 Cumulative Global Cases
Data from WHO Coronavirus Disease (COVID-19) Dashboard, reported on 20th June 2021
Source: World Health Organization
Global Vaccinations Against COVID-19
Official data collated by Our World in Data - data up to 20th June 2021 at 11:20 (London time)
Source: Our World in Data
For full vaccination data, Our World in Data state: "Total number of people who received all doses prescribed by the vaccination protocol. This data is only available for countries which report the breakdown of doses administered by first and second doses."
Total UK COVID-19 Cases
Data for 24 hour period, reported on 20-06-21
Source: Public Health England
COVID-19 in the African Region
Data for 24 hour period, reported on 20-06-21
Source: World Health Organization
COVID-19 in the Eastern Mediterranean Region
Data for 24 hour period, reported on 20-06-21
Source: World Health Organization
Latest COVID-19 Publications and Guidelines:
A selection of recent publications and useful clinical guidance from scientific journals
RECOVERY Collaborative Group, Horby PW, Mafham M, et al. Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. medRxiv 2021.06.15.21258542; doi: 10.1101/2021.06.15.21258542
Li X, Ostropolets A, Makadia R, et al. Characterizing the incidence of adverse events of special interest for COVID-19 vaccines across eight countries: a multinational network cohort study. BMJ 2021;373:n1435. doi: 10.1136/bmj.n1435
Nature Communications: Design of COVID-19 staged alert systems to ensure healthcare capacity with minimal closures
Yang H, Sürer Ö, Duque D, et al. Design of COVID-19 staged alert systems to ensure healthcare capacity with minimal closures. Nat Commun. 2021 Jun 18;12(1):3767. doi: 10.1038/s41467-021-23989-x. PMID: 34145252.
NEJM: Immunotherapy for MIS-C - IVIG, Glucocorticoids, and Biologics (Editorial)
DeBiasi RL. Immunotherapy for MIS-C - IVIG, Glucocorticoids, and Biologics. N Engl J Med. 2021 Jun 16. doi: 10.1056/NEJMe2108276. Epub ahead of print. PMID: 34133878.
Lancet Glob Health: Resetting the agenda for antibiotic resistance through a health systems perspective
Cars O, Chandy SJ, Mpundu M, et al. Resetting the agenda for antibiotic resistance through a health systems perspective. Lancet Glob Health. 2021 Jul;9(7):e1022-e1027. doi: 10.1016/S2214-109X(21)00163-7. PMID: 34143980.
Educational Resources:
WHO: COVID-19 Course Series and Vaccine Series
"Real-time training during global emergencies is critical for effective preparedness and response. The COVID-19 channel provides learning resources for health professionals, decision-makers and the public for the outbreak of coronavirus disease (COVID-19)." (WHO 2020)
Johns Hopkins University: Understanding the COVID-19 Pandemic
BMJ Best Practice: Coronavirus disease 2019 (COVID-19) - clinical decision support tool
Elsevier: COVID-19 Health Education resource center, including the Health Education Faculty Hub
NEJM: Covid-19 Vaccine Resource Center
BMJ: Covid-19 vaccination hesitancy
BMJ: A living WHO guideline on drugs to prevent covid-19
NEJM: Covid-19 Rx: Treatment Simulations
BMJ: Mask related acne (“maskne”) and other facial dermatoses
MedShr Open: COVID-19 Articles
The COVID-19 Hub on MedShr Open includes a selection of articles covering a range of topics related to COVID-19, ranging from emerging therapies, long-term effects of COVID-19, and considering the effects of the pandemic on other essential healthcare services.
.png)
Global Health Data for COVID-19
Global.health - a Data Science Initiative - open public health COVID-19 dataset to advance the response to infectious diseases
The Institute for Health Metrics and Evaluation (IHME)
Research related to COVID-19
Below is a list of links to organisations who are making great efforts to categorise, evaluate and summarise the vast catalogue of COVID-19 research. If you discover any other great resources please feel free to share these in the comments section below.
Global research on coronavirus disease (COVID-19) - WHO Global research database and links to further research catalogues
LitCovid - a curated literature hub for tracking up-to-date scientific information about COVID-19
Public Health Emergency COVID-19 Initiative - PubMed Central
COVID-19 Science Updates - Centers for Disease Control and Prevention
Coronavirus Disease 2019 (COVID-19) Treatment Guidelines - National Institutes of Health
ClinicalTrials.gov - COVID-19 clinical trials
Finding the evidence: Coronavirus – Knowledge & Library Services - Public Health England
Coronavirus (COVID-19) - Cochrane resources and news - Cochrane
India COVID-19 Crisis Support Group
A new group has been launched as part of MedShr's COVID-19 education programme in response to the current challenges in India. The group is intended to be a dedicated place for all healthcare professionals to share information and resources, and discuss how to manage increasingly unwell patients with limited resources, as well as giving access to international experts in COVID-19.
Weekly Update by MedShr Open Editorial Team
Loading Author...
Sign in or Register to comment